Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in Neurochem Res

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    October 2021
  1. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    PubMed     Abstract available


  2. MISHRA AK, Dixit A
    Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
    Neurochem Res. 2021 Oct 12. pii: 10.1007/s11064-021-03464.
    PubMed     Abstract available


    August 2021
  3. ZHONG Z, Chen W, Gao H, Che N, et al
    Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-kappaB Pathway Stimulated by alpha-Synuclein.
    Neurochem Res. 2021 Aug 4. pii: 10.1007/s11064-021-03411.
    PubMed     Abstract available


  4. XU F, Wang H, Tian J, Xu H, et al
    Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Neurochem Res. 2021;46:2192-2203.
    PubMed     Abstract available


    July 2021
  5. PEREZ-BARRON G, Montes S, Aguirre-Vidal Y, Santiago M, et al
    Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP(+) Model of Parkinson's Disease.
    Neurochem Res. 2021 Jul 14. pii: 10.1007/s11064-021-03379.
    PubMed     Abstract available


    June 2021
  6. LIU X, Wang C, Liu W, Song S, et al
    Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
    Neurochem Res. 2021 Jun 7. pii: 10.1007/s11064-021-03363.
    PubMed     Abstract available


    April 2021
  7. WANG X, Liu Z, Wang F
    MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03333.
    PubMed     Abstract available


  8. RATHORE AS, Birla H, Singh SS, Zahra W, et al
    Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03334.
    PubMed     Abstract available


  9. ZHENG Y, Liu J, Zhuang J, Dong X, et al
    Silencing of UCA1 Protects Against MPP(+)-Induced Cytotoxicity in SK-N-SH Cells via Modulating KCTD20 Expression by Sponging miR-423-5p.
    Neurochem Res. 2021;46:878-887.
    PubMed     Abstract available


    March 2021
  10. LIU X, Liu S, Tang Y, Pu Z, et al
    Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Diseas
    Neurochem Res. 2021 Mar 15. pii: 10.1007/s11064-021-03293.
    PubMed     Abstract available


  11. ZENG X, An H, Yu F, Wang K, et al
    Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Neurochem Res. 2021 Mar 1. pii: 10.1007/s11064-021-03262.
    PubMed     Abstract available


    February 2021
  12. XIN C, Liu J
    Long Non-coding RNAs in Parkinson's Disease.
    Neurochem Res. 2021 Feb 5. pii: 10.1007/s11064-021-03230.
    PubMed     Abstract available


    January 2021
  13. RAJPUT C, Sarkar A, Sachan N, Rawat N, et al
    Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Neurochem Res. 2021 Jan 5. pii: 10.1007/s11064-020-03187.
    PubMed     Abstract available


  14. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    PubMed     Abstract available


  15. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    PubMed     Abstract available


    November 2020
  16. AVCI B, Gunaydin C, Guvenc T, Yavuz CK, et al
    Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Neurochem Res. 2020 Nov 28. pii: 10.1007/s11064-020-03186.
    PubMed     Abstract available


  17. LIU T, Zhang Y, Liu W, Zhao J, et al
    LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
    Neurochem Res. 2020 Nov 26. pii: 10.1007/s11064-020-03157.
    PubMed     Abstract available


  18. DONG Y, Xiong J, Ji L, Xue X, et al
    MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.
    Neurochem Res. 2020 Nov 12. pii: 10.1007/s11064-020-03166.
    PubMed     Abstract available


    September 2020
  19. PARAMBI DGT, Saleem U, Shah MA, Anwar F, et al
    Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease.
    Neurochem Res. 2020 Sep 16. pii: 10.1007/s11064-020-03130.
    PubMed     Abstract available


    July 2020
  20. LI W, Goshima Y, Ohshima T
    Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2020 Jul 9. pii: 10.1007/s11064-020-03086.
    PubMed     Abstract available


    June 2020
  21. ZHUANG W, Cai M, Li W, Chen C, et al
    Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease.
    Neurochem Res. 2020 Jun 17. pii: 10.1007/s11064-020-03067.
    PubMed     Abstract available


  22. QIAO CM, Sun MF, Jia XB, Li Y, et al
    Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
    Neurochem Res. 2020 Jun 16. pii: 10.1007/s11064-020-03074.
    PubMed     Abstract available


    May 2020
  23. SINGH A, Tripathi P, Yadawa AK, Singh S, et al
    Promising Polyphenols in Parkinson's Disease Therapeutics.
    Neurochem Res. 2020 May 27. pii: 10.1007/s11064-020-03058.
    PubMed     Abstract available


    April 2020
  24. ZHANG Y, Xia Q, Lin J
    LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3.
    Neurochem Res. 2020 Apr 30. pii: 10.1007/s11064-020-03035.
    PubMed     Abstract available


    January 2020
  25. LIN F, Wu D, Lin C, Cai H, et al
    Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.
    Neurochem Res. 2020 Jan 16. pii: 10.1007/s11064-020-02962.
    PubMed     Abstract available


    November 2019
  26. MAZURSKYY A, Howitt J
    Initiation and Transmission of alpha-Synuclein Pathology in Parkinson's Disease.
    Neurochem Res. 2019 Nov 11. pii: 10.1007/s11064-019-02896.
    PubMed     Abstract available


    October 2019
  27. ESSA MM, Subash S, Dhanalakshmi C, Manivasagam T, et al
    Correction to: Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2019 Oct 18. pii: 10.1007/s11064-019-02887.
    PubMed     Abstract available


    September 2019
  28. ZHANG Q, Lei YH, Zhou JP, Hou YY, et al
    Role of PGC-1alpha in Mitochondrial Quality Control in Neurodegenerative Diseases.
    Neurochem Res. 2019;44:2031-2043.
    PubMed     Abstract available


    August 2019
  29. BETHARIA S, Rondomicronn-Ortiz AN, Brown DA
    Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells.
    Neurochem Res. 2019;44:1878-1892.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: